Typhoid Fever
exp date isn't null, but text field is
Introduction
- A multisystemic illness caused primarily by Salmonella enterica serotype typhi and, to a lesser extent, S. enterica serotypes paratyphi A, B, and C
- It is usually spread through contaminated food or water
- Once Salmonella typhi bacteria are eaten or drunk, they multiply and spread into the bloodstream
- Risk is higher in populations that lack access to safe water and adequate sanitation.
- Humans are the only reservoir for salmonella.
- Incidence of chronic carriage is higher among women and persons with biliary abnormalities: gall stones, carcinoma of the gall bladder; also higher in persons with gastrointestinal malignancies
Clinical features
- Incubation period ranges from 3 - 21 days
- Prolonged fever (38.8C to 40.5-C)
- A prodrome of non-specific symptoms:
- Chills
- Headache
- Anorexia
- Cough
- Weakness
- Sore throat
- Dizziness
- Muscle pains
- Gastro-intestinal:
- Diarrhoea or constipation
- Abdominal pain Rash (rose spots)
- Hepato-splenomegaly
- Epistaxis
- Relative bradycardia
Complications
- Neuropsychiatric symptoms
- Intestinal perforation
- Gastro-intestinal haemorrhage
- Pancreatitis
- Hepatitis
- Splenic abscesses
- Meningitis
- Nephritis
- Pneumonia
- Osteomyelitis
- Chronic carrier state
Investigations
- A positive culture is the 'gold standard' for the diagnosis of typhoid fever
- Specimens for culture may be obtained from the blood, stool, urine, bone marrow; gastric and intestinal secretions
- There are no diagnostic tests other than positive cultures
Non-specific
Full Blood Count
- Leucopenia, neutropenia, leucocytosis can develop early, especially in children; late if complicated by intestinal perforation or secondary infection
Liver function tests
- Values may be elevated
Electrocardiography:
- ST and T wave abnormalities may be present
Serological tests
Widal test gives high rates of false positives and negatives
Treatment goals
- Eliminate S. typhi and S. paratyphi
- Prevent complications
- Prevent chronic carrier status
Drug treatment
Ceftriaxone
Adult: 1 g daily by deep intramuscular injection or by intravenous injection over at least 2 - 4 minutes; 2 - 4 g daily in severe infection
May also be given by intravenous infusion
Child:
Neonate, 20 - 50 mg/kg daily by intravenous injection over 60 minutes;
Infant and child under 50 kg: 20 - 50 mg/kg daily; up to 80 mg/kg in severe infection;
Over 50 kg: adult dose
Doses of 50 mg/kg and above should be given by intravenous infusion only
Intramuscular doses over 1 g should be divided between more than one site; single intravenous doses above 1 g should be given by intravenous infusion only
Or:
Ciprofloxacin
Adult: 500 - 750 mg orally every 12 hours
Or:
200 - 400 mg every 12 hours by intravenous injection over 30 - 60 minutes
Child and adolescent: not recommended
Parenteral fluid administration
Treat complications
Notable adverse drug reactions, contraindications and caution
Ciprofloxacin:
- Diarrhoea, nausea, vomiting, abdominal discomfort, headache (which are themselves features of the disease)
- Should be given with caution in pregnancy and during breastfeeding
- Not recommended for children or adolescents
Non-drug treatment
- Nursing care
- Enteral or parenteral nutrition
Prevention
- Eliminate Salmonella by effective treatment of cases, improved sewage management, improved water treatment and improved food hygiene (production, transit, storage and utilization)
- Typhoid immunization is recommended for those at risk
- Not a substitute for scrupulous personal and environmental hygiene
- Identify, and treat chronic carriers with amoxicillin or ciprofloxacin daily for 4 - 6 weeks
- In patients with urolithiasis and schistosomiasis appropriate treatment should be instituted
- Correct anatomic abnormalities associated with the disease surgically
- Cholecystectomy may be required in some cases